Apogee Therapeutics, Inc Common Stock

Yahoo Finance • 18 hours ago

Why Apogee Slipped On Its Dupixent-Rivaling Eczema Results

Apogee Therapeutics revealed mixed results for its experimental eczema treatment Wednesday, and the stock dropped. Continue Reading... Full story

Yahoo Finance • yesterday

Apogee Therapeutics Shares Surge Following $1.3 Billion Blackstone Financing Partnership (APOG)

medical research 17 ©This Is Engineering Shares of Apogee Therapeutics (NASDAQ:APOG) climbed roughly 16% in premarket trading on Wednesday after the biotechnology company announced a $1.3 billion financing agreement with Blackstone Life S... Full story

Yahoo Finance • last month

Apogee Therapeutics Inc. (APGE): Primary Challenger to Established Blockbusters

We just covered the Billionaire Joe Edelman’s 10 Stock Picks with Huge Upside Potential and Apogee Therapeutics, Inc. (NASDAQ:APGE) ranks 6th on this list. Elite money managers are aggressively accumulating Apogee Therapeutics, Inc. (NASD... Full story

Yahoo Finance • last month

Merck & Co Inc: A Significant Addition to Eaton Vance Worldwide Health Sciences Fund

This article first appeared on GuruFocus. Exploring the Fund's Strategic Moves in the Healthcare Sector Eaton Vance Worldwide Health Sciences Fund (Trades, Portfolio) recently submitted its N-PORT filing for the first quarter of 2026, re... Full story

Yahoo Finance • 2 months ago

Apogee Therapeutics prices upsized $350M offering at $70 a share

Apogee Therapeutics (APGE [https://seekingalpha.com/symbol/APGE]) has announced the pricing [https://seekingalpha.com/pr/20450118-apogee-therapeutics-inc-announces-pricing-of-350-million-underwritten-public-offering] of an upsized public o... Full story

Yahoo Finance • 2 months ago

Apogee Therapeutics, Inc. Announces Pricing of $350 Million Underwritten Public Offering

SAN FRANCISCO and BOSTON, March 24, 2026 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with the potential for best-in-class profiles in the large... Full story

Yahoo Finance • 2 months ago

Stocks Sharply Higher as President Trump Seeks to End Iran War

The S&P 500 Index ($SPX) (SPY) on Monday closed up +1.15%, the Dow Jones Industrial Average ($DOWI) (DIA) closed up +1.38%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +1.22%.  June E-mini S&P futures (ESM26) rose +1.14%, and June E-m... Full story

Yahoo Finance • 2 months ago

How Apogee, Up 20%, Plans To Take On Rival Regeneron's Eczema Drug

Apogee Therapeutics reported a "best case scenario" Monday for its potential rival to eczema drug, Dupixent. Continue Reading... Full story

Yahoo Finance • 2 months ago

How Apogee, Up Almost 20%, Plans To Take On Rival Regeneron's Eczema Drug

Apogee Therapeutics reported a "best case scenario" Monday for its potential rival to eczema drug, Dupixent. Continue Reading... Full story

Yahoo Finance • 2 months ago

Stocks making the biggest moves midday: Palantir, Flutter, United Airlines, Synopsys, Insmed & more

Check out some of the companies making the biggest midday moves: Airlines — Delta Air Lines , United Airlines , Southwest Airlines and American Airlines surged roughly 4% after President Donald Trump said the U.S. wouldn't strike key energ... Full story

Yahoo Finance • 2 months ago

Stocks Rally as President Trump Eases Iran Threats

The S&P 500 Index ($SPX) (SPY) today is up +2.10%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +2.30%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +2.19%.  June E-mini S&P futures (ESM26) are up +2.14%, and June E-mini Nasdaq fut... Full story

Yahoo Finance • 2 months ago

Stocks Rebound as Crude Oil Sinks After President Trump Eases Iran Threats

The S&P 500 Index ($SPX) (SPY) today is up +1.73%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +1.97%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +1.79%.  June E-mini S&P futures (ESM26) are up +1.47%, and June E-mini Nasdaq fut... Full story

Yahoo Finance • 2 months ago

Top Midday Stories: Trump Orders 5-Day Postponement of Strikes on Iranian Energy Sites; JPMorgan Launches $8 Billion Junk-Bond Sale for EA Buyout

All three major US stock indexes were up in late-morning trading Monday, after President Donald Trum PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 2 months ago

Apogee Therapeutics to Host Conference Call to Report Part A 52-Week Data from the Phase 2 APEX Trial of Zumilokibart (APG777) in Patients with Moderate-to-Severe Atopic Dermatitis on March 23, 2026

SAN FRANCISCO and BOSTON, March 22, 2026 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with potential for best-in-class profiles in the largest i... Full story

Yahoo Finance • 2 months ago

Signal or Noise: What VR Adviser's Spyre Theraputics Buy Means for Fools

Key Points VR Adviser, LLC added 1,000,000 shares of Spyre Therapeutics; estimated trade size is $25.78 million (based on quarterly average pricing). The quarter-end value of the position increased by $75.73 million, reflecting both tradi... Full story

Yahoo Finance • 2 months ago

What to Make of VR Adviser's Big Ocular Therapeutix Sell-Down

On February 17, 2026, VR Adviser, LLC disclosed in a U.S. Securities and Exchange Commission filing that it sold 5,845,915 shares of Ocular Therapeutix(NASDAQ:OCUL), an estimated $71.01 million trade based on quarterly average pricing. VR... Full story

Yahoo Finance • 2 months ago

Block upgraded, Starbucks downgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Truist upgraded Block (XYZ) to Buy fro... Full story

Yahoo Finance • 2 months ago

VR Adviser Adds Over 1 Million Savara Shares

According to a filing with the Securities and Exchange Commission dated Feb. 17, VR Adviser, LLC increased its position in Savara(NASDAQ:SVRA) by 1,059,332 shares during the fourth quarter. The fund’s Savara stake ended the quarter valued... Full story

Yahoo Finance • 3 months ago

Wedbush Raises Price Target on Apogee Therapeutics (APGE)

Apogee Therapeutics Inc. (NASDAQ:APGE) is one of the 10 most shorted biotech stocks to buy according to hedge funds. On March 3, Wedbush increased its price target on Apogee Therapeutics Inc. (NASDAQ:APGE) from $90 to $95. The firm mainta... Full story

Yahoo Finance • 3 months ago

Investment Manager Fully Exits Immunome Stock in $37.3 Million Sale, According to Latest SEC Filing

On February 17, 2026, Opaleye Management Inc. reported selling out its entire stake in Immunome(NASDAQ:IMNM), an estimated $37.30 million trade based on quarterly average pricing. What Happened According to its SEC filing dated February... Full story